In the current pandemic conditions, scientific journals have sped up the time from submission to publication of COVID-19-related research papers, and scientists have uploaded thousands of them to open-access, preprint […]
The U.S. Food and Drug Administration (FDA) has issued a final guidance on “Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank” outlining the agency’s current thinking regarding penalties imposed […]
All of those lofty goals and high aspirations associated with the term “patient centricity” won’t meet their potential unless all stakeholders come together to swap ideas, confront challenges, and share […]
The U.S. Food and Drug Administration (FDA) has created a special emergency program for possible coronavirus therapies, the Coronavirus Treatment Acceleration Program (CTAP). The program uses every available method to […]
Current and prospective clinical trial practitioners sell themselves and the future of the industry short if they view technology as a threat and not an opportunity, says long-time clinical trial […]